Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies

Journal of Ophthalmic & Vision Research

卷:16

LucDuchateau¹  PaulWillems¹  Brian C.Joondeph¹  ThomasRaber¹  JosephMarkoff¹ 

[1] Thomas Jefferson Medical College, Philadelphia, Pennsylvania, USA;

关键词: ocriplasmin;    full-thickness macular hole;    vitreomacular adhesion;    symptomatic vitreomacular adhesion;    vitreomacular traction;    vitreoretinal interface;   

DOI  :  10.18502/jovr.v16i1.8250

来源: DOAJ

【 摘 要 】

Purpose: To assess the effect of patient baseline characteristics on the efficacy of ocriplasmin treatment for symptomatic vitreomacular adhesion (VMA) with full-thickness macular hole (FTMH) from phase 3/4 studies.Methods: Patients with symptomatic VMA and FTMH at baseline and receiving ocriplasmin treatment 125μg were pooled from the MIVI-TRUST, OASIS, and ORBIT studies. Multivariable logistic regression analysis was used to evaluate whether patient baseline characteristics were predictors of having VMA resolution by Day 28 and FTMH closure by Month 6.Results: Two hundred and seventy-four patients receiving ocriplasmin treatment were assessed. Overall, 22.6% (62/274) of the patients experienced both VMA resolution by Day 28 and non-surgical FTMH closure by Month 6. Patients with FTMH≤250 µm at baseline had a significantly higher success rate compared to those with FTMH>400 µm (29.9% [41/137] vs 2.2% [1/48]; P = 0.009). In patients with VMA resolution by Day 28, both small FTMH size (P = 0.001) and FTMH width at RPE (P = 0.012) were significantly associated with a higher FTMH closure rate. Patients with VMA resolution had higher rates of FTMH closure. Previously identified baseline predictive factors, including age, lens status, or presence of epiretinal membrane (ERM) were not found to be predictive of both VMA release and FTMH closure.Conclusion: The analysis revealed that FMTH≤250 µm was the only factor predictive for achieving both pharmacological VMA resolution by Day 28 and nonsurgical FTMH closure by Month 6; neither lens status or presence of ERM, previously identified baseline characteristics favoring VMA resolution, showed statistically significant predictive power for both outcomes.

【 授权许可】

Unknown